These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23896587)

  • 1. Phacilitate, Partnering For Vaccine Emerging Markets June 10-11 2013, Berlin session: Brazil and Argentina--Profiling Vaccine Demand, Supply and Aspirations.
    Valencia IM
    Hum Vaccin Immunother; 2013 Sep; 9(9):2019-21. PubMed ID: 23896587
    [No Abstract]   [Full Text] [Related]  

  • 2. Partnering for Vaccine Emerging Markets--Berlin, June 10-11, 2013: balancing vaccine quality, capacity, and cost-of-goods in emerging markets.
    Onraedt A
    Hum Vaccin Immunother; 2013 Sep; 9(9):2022-4. PubMed ID: 23966097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key drivers behind the development of global vaccine market.
    Gréco M
    Vaccine; 2001 Feb; 19(13-14):1606-10. PubMed ID: 11166882
    [No Abstract]   [Full Text] [Related]  

  • 4. Economical value of vaccines for the developing countries--the case of Instituto Butantan, a public institution in Brazil.
    Ho PL; Miyaji EN; Oliveira ML; Dias Wde O; Kubrusly FS; Tanizaki MM; Martins EA; Raw I
    PLoS Negl Trop Dis; 2011 Nov; 5(11):e1300. PubMed ID: 22140586
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacovigilance capacity strengthening for WHO prequalification: The case of the trivalent influenza vaccine manufactured by Instituto Butantan.
    Koike ME; Gattás VL; Lucchesi MBB; Moura de Oliveira MM; Vanni T; Thomé BDC; Menang O; Socquet M; Precioso AR
    Vaccine; 2019 Dec; 37(52):7560-7565. PubMed ID: 31590933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phacilitate vaccine forum Barcelona 2009.
    Silman NJ; Rivera LM; Wheat J
    Expert Rev Vaccines; 2009 Oct; 8(10):1329-31. PubMed ID: 19803754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of vaccine stockouts on immunization coverage in Nigeria.
    Gooding E; Spiliotopoulou E; Yadav P
    Vaccine; 2019 Aug; 37(35):5104-5110. PubMed ID: 31320215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of vaccine programs across 94 low- and middle-income countries.
    Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
    Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WHO expectation and industry goals.
    Vandersmissen W
    Vaccine; 2001 Feb; 19(13-14):1611-5. PubMed ID: 11166883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergency response vaccines--a challenge for the public sector and the vaccine industry.
    Milstien J; Lambert S
    Vaccine; 2002 Nov; 21(1-2):146-54. PubMed ID: 12443673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine supply, demand, and policy: a primer.
    Muzumdar JM; Cline RR
    J Am Pharm Assoc (2003); 2009; 49(4):e87-99. PubMed ID: 19589753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of rotavirus vaccination in Argentina.
    Urueña A; Pippo T; Betelu MS; Virgilio F; Hernández L; Giglio N; Gentile Á; Diosque M; Vizzotti C
    Vaccine; 2015 May; 33 Suppl 1():A126-34. PubMed ID: 25919152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dengue, zika, chikungunya and the development of vaccines].
    Kantor IN
    Medicina (B Aires); 2018; 78(1):23-28. PubMed ID: 29360072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential effects of introducing microneedle patch vaccines into routine vaccine supply chains.
    Wedlock PT; Mitgang EA; Elsheikh F; Leonard J; Bakal J; Welling J; Crawford J; Assy E; Magadzire BP; Bechtel R; DePasse JV; Siegmund SS; Brown ST; Lee BY
    Vaccine; 2019 Jan; 37(4):645-651. PubMed ID: 30578088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emergence of vaccine hesitancy among upper-class Brazilians: Results from four birth cohorts, 1982-2015.
    Silveira MF; Buffarini R; Bertoldi AD; Santos IS; Barros AJD; Matijasevich A; Menezes AMB; Gonçalves H; Horta BL; Barros FC; Barata RB; Victora CG
    Vaccine; 2020 Jan; 38(3):482-488. PubMed ID: 31718899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination Coverage Among Children Aged 19-35 Months - United States, 2016.
    Hill HA; Elam-Evans LD; Yankey D; Singleton JA; Kang Y
    MMWR Morb Mortal Wkly Rep; 2017 Nov; 66(43):1171-1177. PubMed ID: 29095807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines, our shared responsibility.
    Pagliusi S; Jain R; Suri RK;
    Vaccine; 2015 May; 33(19):2197-2202. PubMed ID: 25749248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal immunization in Argentina: A storyline from the prospective of a middle income country.
    Vizzotti C; Neyro S; Katz N; Juárez MV; Perez Carrega ME; Aquino A; Kaski Fullone F
    Vaccine; 2015 Nov; 33(47):6413-9. PubMed ID: 26277071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.